P1.11.59 Effect of IFNG Expression Levels on Real-World Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Receiving Immunotherapy
Back to course
Asset Subtitle
Michael Rossi
Meta Tag
Speaker Michael Rossi
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
Powered By